Examining Systems, Substance Use, and Disenfranchisement: Overview and Proceedings of the 2022 AMERSA Conference-Reference-Cited by-同舟云学术

Examining Systems, Substance Use, and Disenfranchisement: Overview and Proceedings of the 2022 AMERSA Conference

Published:2023-01 Issue:1-2 Volume:44 Page:4-11
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Bagley Sarah M.¹²³,Northup Rebecca⁴,Wason Kristin¹³,Bratberg Jeffrey⁵,Gordon Adam J.⁶⁷,Oliva Elizabeth⁸

Affiliation:

1. Section of General Internal Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA

2. Division of General Pediatrics, Department of Pediatrics, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA

3. Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA

4. AMERSA, Inc, RI, USA

5. Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, RI, USA

6. Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

7. Vulnerable Veteran Innovative Patient-Aligned-Care-Team, Informatics, Decision-Enhancement and Analytic Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA

8. VA Palo Alto Health Care System, Palo Alto, CA, USA

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://journals.sagepub.com/doi/pdf/10.1177/08897077231169569

Reference46 articles.

1. Commentary On The 40th Anniversary of AMERSA: AMERSA at 40: How It All Began And How It Survived

2. Association for Medical Education and Research in Substance Abuse

3. National Drug Control Strategy. The White House, Executive Office of the President. Office of National Drug Control Policy; 2022.

4. Drug Overdose Deaths in the United States, 2001–2021

5. Rising Numbers of Deaths Involving Fentanyl and Fentanyl Analogs, Including Carfentanil, and Increased Usage and Mixing With Non-opioids. Centers for Disease Control Health Alert Network; 2018.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts;International Journal of Drug Policy;2023-12